FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2183003255> ?p ?o ?g. }

• W2183003255 endingPage "14" @default.
• W2183003255 startingPage "16308" @default.
• W2183003255 abstract "High-dose chemotherapy (HDC) applied together with autologous stem cell transplantation (ASCT) is a commonly used treatment modality in patients with malignant lymphoma. At present, there is a limited number of studies which compare toxicity and efficacy of various high-dose regimens applied in the treatment of malignant lymphoma. For this reason, the aim of this study was to investigate the efficacy and toxicity of BuCyE (busulfan, cyclophosphamide and etoposide) and BEAM (carmustine, etoposide, cytarabine and melphalan) preparative regimens in the patients with malignant lymphoma scheduled for autologous stem cell transplantation. Between November, 2010 and April, 2015, 42 patients with relapsed or refractory malignant lymphoma who underwent autologous stem cell transplantation following BEAM (n=11) and BuCyE (n=31) preparative regimens were analyzed at Bone Marrow Transplantation Unit of TurgutOzal Medicine Center in Turkey. The groups were compared in terms of patient characteristics, hematopoietic engraftment time, toxicity profiles and survival. No significant differences were detected between the groups with regard to age, gender distribution, international prognostic index, ASCT indications, disease status at the time of ASCT and type of lymphoma (P>0.05). Median number of infused CD34+ cells/kg, neutrophil and platelet engraftment statuses of BuCyE and BEAM groups were found to be similar (P>0.05). More patients in BuCyE group developed mucositis and nausea, but this difference was not statistically significant (P>0.05). A similar statistically insignificant difference was seen in that infectious complications occurred more commonly in BEAM group (P>0.05). Overall survival and event-free survival rates were not significantly different between the groups (P>0.05). BuCyE is a conditioning regimen which can be effectively used as an alternative to BEAM in the patients with malignant lymphoma undergoing ASCT. Moreover, toxicity rates of both regimens are similar. In order to comprehend the effect of each HDC regimen, further evidence-based data obtained from the studies involving larger sample sizes are required." @default.
• W2183003255 created "2016-06-24" @default.
• W2183003255 creator A5008969241 @default.
• W2183003255 creator A5022059136 @default.
• W2183003255 creator A5022584265 @default.
• W2183003255 creator A5024437569 @default.
• W2183003255 creator A5055141457 @default.
• W2183003255 creator A5059747985 @default.
• W2183003255 creator A5076296075 @default.
• W2183003255 date "2015-01-01" @default.
• W2183003255 modified "2023-10-17" @default.
• W2183003255 title "Can BuCyE conditioning regimen be an alternative treatment to BEAM at autologous transplantation in malignant lymphoma patients?: a single center experience." @default.
• W2183003255 cites W1912693401 @default.
• W2183003255 cites W1975390846 @default.
• W2183003255 cites W1976757394 @default.
• W2183003255 cites W1978078950 @default.
• W2183003255 cites W1997241992 @default.
• W2183003255 cites W2057254050 @default.
• W2183003255 cites W2059524199 @default.
• W2183003255 cites W2063553062 @default.
• W2183003255 cites W2071068894 @default.
• W2183003255 cites W2131508403 @default.
• W2183003255 cites W2134658503 @default.
• W2183003255 cites W2145361930 @default.
• W2183003255 cites W2256236774 @default.
• W2183003255 cites W2334006561 @default.
• W2183003255 cites W4205736005 @default.
• W2183003255 cites W76240476 @default.
• W2183003255 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4659037" @default.
• W2183003255 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26629149" @default.
• W2183003255 hasPublicationYear "2015" @default.
• W2183003255 type Work @default.
• W2183003255 sameAs 2183003255 @default.
• W2183003255 citedByCount "3" @default.
• W2183003255 countsByYear W21830032552018 @default.
• W2183003255 countsByYear W21830032552019 @default.
• W2183003255 countsByYear W21830032552023 @default.
• W2183003255 crossrefType "journal-article" @default.
• W2183003255 hasAuthorship W2183003255A5008969241 @default.
• W2183003255 hasAuthorship W2183003255A5022059136 @default.
• W2183003255 hasAuthorship W2183003255A5022584265 @default.
• W2183003255 hasAuthorship W2183003255A5024437569 @default.
• W2183003255 hasAuthorship W2183003255A5055141457 @default.
• W2183003255 hasAuthorship W2183003255A5059747985 @default.
• W2183003255 hasAuthorship W2183003255A5076296075 @default.
• W2183003255 hasConcept C126322002 @default.
• W2183003255 hasConcept C141071460 @default.
• W2183003255 hasConcept C143998085 @default.
• W2183003255 hasConcept C2776694085 @default.
• W2183003255 hasConcept C2776755627 @default.
• W2183003255 hasConcept C2777408962 @default.
• W2183003255 hasConcept C2778119113 @default.
• W2183003255 hasConcept C2778496288 @default.
• W2183003255 hasConcept C2778684742 @default.
• W2183003255 hasConcept C2779050716 @default.
• W2183003255 hasConcept C2779338263 @default.
• W2183003255 hasConcept C2780073493 @default.
• W2183003255 hasConcept C2780147359 @default.
• W2183003255 hasConcept C2780611847 @default.
• W2183003255 hasConcept C2781413609 @default.
• W2183003255 hasConcept C2911091166 @default.
• W2183003255 hasConcept C71924100 @default.
• W2183003255 hasConcept C90924648 @default.
• W2183003255 hasConceptScore W2183003255C126322002 @default.
• W2183003255 hasConceptScore W2183003255C141071460 @default.
• W2183003255 hasConceptScore W2183003255C143998085 @default.
• W2183003255 hasConceptScore W2183003255C2776694085 @default.
• W2183003255 hasConceptScore W2183003255C2776755627 @default.
• W2183003255 hasConceptScore W2183003255C2777408962 @default.
• W2183003255 hasConceptScore W2183003255C2778119113 @default.
• W2183003255 hasConceptScore W2183003255C2778496288 @default.
• W2183003255 hasConceptScore W2183003255C2778684742 @default.
• W2183003255 hasConceptScore W2183003255C2779050716 @default.
• W2183003255 hasConceptScore W2183003255C2779338263 @default.
• W2183003255 hasConceptScore W2183003255C2780073493 @default.
• W2183003255 hasConceptScore W2183003255C2780147359 @default.
• W2183003255 hasConceptScore W2183003255C2780611847 @default.
• W2183003255 hasConceptScore W2183003255C2781413609 @default.
• W2183003255 hasConceptScore W2183003255C2911091166 @default.
• W2183003255 hasConceptScore W2183003255C71924100 @default.
• W2183003255 hasConceptScore W2183003255C90924648 @default.
• W2183003255 hasIssue "9" @default.
• W2183003255 hasLocation W21830032551 @default.
• W2183003255 hasOpenAccess W2183003255 @default.
• W2183003255 hasPrimaryLocation W21830032551 @default.
• W2183003255 hasRelatedWork W1670193918 @default.
• W2183003255 hasRelatedWork W1987997012 @default.
• W2183003255 hasRelatedWork W2115819145 @default.
• W2183003255 hasRelatedWork W2163996738 @default.
• W2183003255 hasRelatedWork W2183003255 @default.
• W2183003255 hasRelatedWork W2554728082 @default.
• W2183003255 hasRelatedWork W2563189124 @default.
• W2183003255 hasRelatedWork W2564791082 @default.
• W2183003255 hasRelatedWork W2582424465 @default.
• W2183003255 hasRelatedWork W4220672365 @default.
• W2183003255 hasVolume "8" @default.
• W2183003255 isParatext "false" @default.
• W2183003255 isRetracted "false" @default.

• next